PortfoliosLab logoPortfoliosLab logo
ELV vs. CVS
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ELV vs. CVS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Elevance Health Inc (ELV) and CVS Health Corporation (CVS). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ELV achieves a 20.02% return, which is significantly lower than CVS's 24.42% return. Over the past 10 years, ELV has outperformed CVS with an annualized return of 13.78%, while CVS has yielded a comparatively lower 3.16% annualized return.


ELV

1D
0.63%
1M
10.60%
YTD
20.02%
6M
27.26%
1Y
8.57%
3Y*
-2.38%
5Y*
3.00%
10Y*
13.78%

CVS

1D
1.20%
1M
7.21%
YTD
24.42%
6M
29.02%
1Y
58.27%
3Y*
14.98%
5Y*
6.17%
10Y*
3.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ELV vs. CVS - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ELV
Elevance Health Inc
20.02%-3.14%-20.72%-6.89%11.83%46.12%7.74%16.33%18.11%58.72%
CVS
CVS Health Corporation
24.42%84.35%-40.77%-12.53%-7.63%54.87%-5.14%17.26%-7.04%-5.75%

Correlation

The correlation between ELV and CVS is 0.47, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.47

Correlation (3Y)
Calculated over the trailing 3-year period

0.44

Correlation (5Y)
Calculated over the trailing 5-year period

0.50

Correlation (10Y)
Calculated over the trailing 10-year period

0.47

Correlation (All Time)
Calculated using the full available price history since Oct 31, 2001

0.39

The correlation between ELV and CVS shifts across timeframes, from 0.39 (all time) to 0.50 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

ELV:

$92.16B

CVS:

$124.17B

EPS

ELV:

$23.46

CVS:

$2.30

PE Ratio

ELV:

17.82

CVS:

42.17

PS Ratio

ELV:

0.47

CVS:

0.30

PB Ratio

ELV:

2.10

CVS:

1.60

Total Revenue (TTM)

ELV:

$200.42B

CVS:

$407.91B

Gross Profit (TTM)

ELV:

$46.43B

CVS:

$56.59B

EBITDA (TTM)

ELV:

$8.92B

CVS:

$9.99B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ELV vs. CVS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ELV
ELV Risk / Return Rank: 4747
Overall Rank
ELV Sharpe Ratio Rank: 5050
Sharpe Ratio Rank
ELV Sortino Ratio Rank: 4444
Sortino Ratio Rank
ELV Omega Ratio Rank: 4646
Omega Ratio Rank
ELV Calmar Ratio Rank: 4949
Calmar Ratio Rank
ELV Martin Ratio Rank: 4848
Martin Ratio Rank

CVS
CVS Risk / Return Rank: 8585
Overall Rank
CVS Sharpe Ratio Rank: 8888
Sharpe Ratio Rank
CVS Sortino Ratio Rank: 8181
Sortino Ratio Rank
CVS Omega Ratio Rank: 8585
Omega Ratio Rank
CVS Calmar Ratio Rank: 8787
Calmar Ratio Rank
CVS Martin Ratio Rank: 8787
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ELV vs. CVS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Elevance Health Inc (ELV) and CVS Health Corporation (CVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ELVCVSDifference
Sharpe ratioReturn per unit of total volatility

-1.67

Sortino ratioReturn per unit of downside risk

-1.78

Omega ratioGain probability vs. loss probability

1.08

1.35

-0.27

Calmar ratioReturn relative to maximum drawdown

0.28

3.56

-3.28

Martin ratioReturn relative to average drawdown

0.51

9.17

-8.66

ELV vs. CVS - Sharpe Ratio Comparison

The current ELV Sharpe Ratio is 0.22, which is lower than the CVS Sharpe Ratio of 1.89. The chart below compares the historical Sharpe Ratios of ELV and CVS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


ELVCVSDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.22

1.89

-1.67

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.10

0.21

-0.10

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.45

0.11

+0.34

Sharpe Ratio (All Time)

Calculated using the full available price history

0.46

0.34

+0.12

Drawdowns

ELV vs. CVS - Drawdown Comparison

The maximum ELV drawdown since its inception was -67.19%, roughly equal to the maximum CVS drawdown of -64.07%. Use the drawdown chart below to compare losses from any high point for ELV and CVS.


Loading charts...

Drawdown Indicators


ELVCVSDifference

Max Drawdown

Largest peak-to-trough decline

-67.19%

-64.07%

-3.12%

Max Drawdown (1Y)

Largest decline over 1 year

-30.60%

-16.44%

-14.16%

Max Drawdown (3Y)

Largest decline over 3 years

-50.38%

-43.98%

-6.40%

Max Drawdown (5Y)

Largest decline over 5 years

-50.38%

-56.79%

+6.41%

Max Drawdown (10Y)

Largest decline over 10 years

-50.38%

-56.79%

+6.41%

Current Drawdown

Current decline from peak

-23.19%

-1.05%

-22.14%

Average Drawdown

Average peak-to-trough decline

-15.29%

-19.55%

+4.26%

Ulcer Index

Depth and duration of drawdowns from previous peaks

16.76%

6.37%

+10.39%

Volatility

ELV vs. CVS - Volatility Comparison

The current volatility for Elevance Health Inc (ELV) is 8.30%, while CVS Health Corporation (CVS) has a volatility of 8.88%. This indicates that ELV experiences smaller price fluctuations and is considered to be less risky than CVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ELVCVSDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.30%

8.88%

-0.58%

Volatility (6M)

Calculated over the trailing 6-month period

27.26%

25.90%

+1.36%

Volatility (1Y)

Calculated over the trailing 1-year period

38.59%

31.07%

+7.52%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

28.93%

29.96%

-1.03%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

30.84%

29.30%

+1.54%

Dividends

ELV vs. CVS - Dividend Comparison

ELV's dividend yield for the trailing twelve months is around 1.64%, less than CVS's 2.74% yield.


PositionTTM20252024202320222021202020192018201720162015
CVS
CVS Health Corporation
2.74%3.35%5.93%3.06%2.36%1.94%2.93%2.69%3.05%2.76%2.15%1.43%
ELV
Elevance Health Inc
1.64%1.95%1.77%1.26%1.00%0.98%1.18%1.06%1.14%1.20%1.81%1.79%

Financials

ELV vs. CVS - Financials Comparison

This section allows you to compare key financial metrics between Elevance Health Inc and CVS Health Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


40.00B60.00B80.00B100.00B20222023202420252026
50.18B
100.43B
(ELV) Total Revenue
(CVS) Total Revenue
Values in USD except per share items

ELV vs. CVS - Profitability Comparison

The chart below illustrates the profitability comparison between Elevance Health Inc and CVS Health Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

15.0%20.0%25.0%30.0%20222023202420252026
18.1%
15.6%
Portfolio components
ELV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Elevance Health Inc reported a gross profit of 9.10B and revenue of 50.18B. Therefore, the gross margin over that period was 18.1%.

CVS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, CVS Health Corporation reported a gross profit of 15.62B and revenue of 100.43B. Therefore, the gross margin over that period was 15.6%.

ELV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Elevance Health Inc reported an operating income of 2.66B and revenue of 50.18B, resulting in an operating margin of 5.3%.

CVS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, CVS Health Corporation reported an operating income of 4.68B and revenue of 100.43B, resulting in an operating margin of 4.7%.

ELV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Elevance Health Inc reported a net income of 1.76B and revenue of 50.18B, resulting in a net margin of 3.5%.

CVS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, CVS Health Corporation reported a net income of 2.94B and revenue of 100.43B, resulting in a net margin of 2.9%.


Frequently Asked Questions


ELV and CVS have a correlation of 0.47, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CVS has higher volatility (8.88%) compared to ELV (8.30%). In terms of maximum drawdown, ELV dropped -67.19% vs CVS's -64.07%.

CVS currently has the higher Sharpe Ratio (1.89 vs 0.22), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ELV and CVS

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer